QIAGEN's TB Testing Business Gets New Exposure at Global Summit — Oct 11th, 2024

Recently, QIAGEN’s QGEN tuberculosis (TB) testing business came into focus, with the company becoming the sponsor of the annual Global TB Summit 2024. Held from Oct. 8-11 in London and online, this summit has become an essential platform for addressing the resurgence of TB, one of the de...

QIAGEN's TB Testing Business Gets New Exposure at Global Summit — Oct 11th, 2024

Recently, QIAGEN’s QGEN tuberculosis (TB) testing business came into focus, with the company becoming the sponsor of the annual Global TB Summit 2024. Held from Oct. 8-11 in London and online, this summit has become an essential platform for addressing the resurgence of TB, one of the de...

Qiagen N.V. (NYSE:QGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? — Oct 18th, 2024

With its stock down 6.5% over the past month, it is easy to disregard Qiagen (NYSE:QGEN). However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty respectable. In this article, we decided to focus on Qiagen's ROE. Return on E...

OPK Gets Additional BARDA Funding to Develop Multispecific Antibodies — Oct 11th, 2024

OPKO Health, Inc.’s OPK company, ModeX Therapeutics Inc., was awarded $35 million of additional funding under an existing contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the U.S. Depar...

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick — Oct 16th, 2024

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks base...

18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker' — Oct 12th, 2024

18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker' Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. As the third-quarter earnings season approaches, Goldman Sachs has issued a note id...

QIAGEN N.V. to release results for Q3 2024 and hold webcast — Oct 10th, 2024

Venlo, The Netherlands, Oct. 10, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the third quarter 2024. Press release date / time: Wednesday, November 6, shortly after 22:05Frankfurt time / 21:05 London time / 16:05...

Qiagen N.V. (NYSE:QGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? — Oct 18th, 2024

With its stock down 6.5% over the past month, it is easy to disregard Qiagen (NYSE:QGEN). However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty respectable. In this article, we decided to focus on Qiagen's ROE. Return on E...

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick — Oct 16th, 2024

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks base...

QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications — Oct 10th, 2024

Portfolio expansion reinforces QIAGEN’s leadership in automated solutions for non-invasive liquid biopsy applications combined with complete workflows // New ccfDNA Kit upgrade with urine protocol for use on EZ1 and 2 instruments designed to enhance liquid biopsy workflows for cancer res...

OPK Gets Additional BARDA Funding to Develop Multispecific Antibodies — Oct 11th, 2024

OPKO Health, Inc.’s OPK company, ModeX Therapeutics Inc., was awarded $35 million of additional funding under an existing contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the U.S. Depar...

OPK Gets Additional BARDA Funding to Develop Multispecific Antibodies — Oct 11th, 2024

OPKO Health, Inc.’s OPK company, ModeX Therapeutics Inc., was awarded $35 million of additional funding under an existing contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the U.S. Depar...

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick — Oct 16th, 2024

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks base...

18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker' — Oct 12th, 2024

18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker' Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. As the third-quarter earnings season approaches, Goldman Sachs has issued a note id...

Qiagen N.V. (NYSE:QGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? — Oct 18th, 2024

With its stock down 6.5% over the past month, it is easy to disregard Qiagen (NYSE:QGEN). However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty respectable. In this article, we decided to focus on Qiagen's ROE. Return on E...

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick — Oct 16th, 2024

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks base...

OPK Gets Additional BARDA Funding to Develop Multispecific Antibodies — Oct 11th, 2024

OPKO Health, Inc.’s OPK company, ModeX Therapeutics Inc., was awarded $35 million of additional funding under an existing contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the U.S. Depar...

18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker' — Oct 12th, 2024

18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker' Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. As the third-quarter earnings season approaches, Goldman Sachs has issued a note id...

QIAGEN's TB Testing Business Gets New Exposure at Global Summit — Oct 11th, 2024

Recently, QIAGEN’s QGEN tuberculosis (TB) testing business came into focus, with the company becoming the sponsor of the annual Global TB Summit 2024. Held from Oct. 8-11 in London and online, this summit has become an essential platform for addressing the resurgence of TB, one of the de...

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick — Oct 16th, 2024

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks base...

Qiagen N.V. (NYSE:QGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? — Oct 18th, 2024

With its stock down 6.5% over the past month, it is easy to disregard Qiagen (NYSE:QGEN). However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty respectable. In this article, we decided to focus on Qiagen's ROE. Return on E...

QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications — Oct 10th, 2024

Portfolio expansion reinforces QIAGEN’s leadership in automated solutions for non-invasive liquid biopsy applications combined with complete workflows // New ccfDNA Kit upgrade with urine protocol for use on EZ1 and 2 instruments designed to enhance liquid biopsy workflows for cancer res...

QIAGEN's TB Testing Business Gets New Exposure at Global Summit — Oct 11th, 2024

Recently, QIAGEN’s QGEN tuberculosis (TB) testing business came into focus, with the company becoming the sponsor of the annual Global TB Summit 2024. Held from Oct. 8-11 in London and online, this summit has become an essential platform for addressing the resurgence of TB, one of the de...

QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications — Oct 10th, 2024

Portfolio expansion reinforces QIAGEN’s leadership in automated solutions for non-invasive liquid biopsy applications combined with complete workflows // New ccfDNA Kit upgrade with urine protocol for use on EZ1 and 2 instruments designed to enhance liquid biopsy workflows for cancer res...

Qiagen N.V. (NYSE:QGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? — Oct 18th, 2024

With its stock down 6.5% over the past month, it is easy to disregard Qiagen (NYSE:QGEN). However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty respectable. In this article, we decided to focus on Qiagen's ROE. Return on E...

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick — Oct 16th, 2024

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks base...

QIAGEN's TB Testing Business Gets New Exposure at Global Summit — Oct 11th, 2024

Recently, QIAGEN’s QGEN tuberculosis (TB) testing business came into focus, with the company becoming the sponsor of the annual Global TB Summit 2024. Held from Oct. 8-11 in London and online, this summit has become an essential platform for addressing the resurgence of TB, one of the de...

18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker' — Oct 12th, 2024

18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker' Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. As the third-quarter earnings season approaches, Goldman Sachs has issued a note id...

QIAGEN's TB Testing Business Gets New Exposure at Global Summit — Oct 11th, 2024

Recently, QIAGEN’s QGEN tuberculosis (TB) testing business came into focus, with the company becoming the sponsor of the annual Global TB Summit 2024. Held from Oct. 8-11 in London and online, this summit has become an essential platform for addressing the resurgence of TB, one of the de...

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick — Oct 16th, 2024

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks base...

QIAGEN's TB Testing Business Gets New Exposure at Global Summit — Oct 11th, 2024

Recently, QIAGEN’s QGEN tuberculosis (TB) testing business came into focus, with the company becoming the sponsor of the annual Global TB Summit 2024. Held from Oct. 8-11 in London and online, this summit has become an essential platform for addressing the resurgence of TB, one of the de...

QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications — Oct 10th, 2024

Portfolio expansion reinforces QIAGEN’s leadership in automated solutions for non-invasive liquid biopsy applications combined with complete workflows // New ccfDNA Kit upgrade with urine protocol for use on EZ1 and 2 instruments designed to enhance liquid biopsy workflows for cancer res...

OPK Gets Additional BARDA Funding to Develop Multispecific Antibodies — Oct 11th, 2024

OPKO Health, Inc.’s OPK company, ModeX Therapeutics Inc., was awarded $35 million of additional funding under an existing contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the U.S. Depar...

OPK Gets Additional BARDA Funding to Develop Multispecific Antibodies — Oct 11th, 2024

OPKO Health, Inc.’s OPK company, ModeX Therapeutics Inc., was awarded $35 million of additional funding under an existing contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the U.S. Depar...

QIAGEN's TB Testing Business Gets New Exposure at Global Summit — Oct 11th, 2024

Recently, QIAGEN’s QGEN tuberculosis (TB) testing business came into focus, with the company becoming the sponsor of the annual Global TB Summit 2024. Held from Oct. 8-11 in London and online, this summit has become an essential platform for addressing the resurgence of TB, one of the de...

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick — Oct 16th, 2024

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks base...

18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker' — Oct 12th, 2024

18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker' Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. As the third-quarter earnings season approaches, Goldman Sachs has issued a note id...

Qiagen N.V. (NYSE:QGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? — Oct 18th, 2024

With its stock down 6.5% over the past month, it is easy to disregard Qiagen (NYSE:QGEN). However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty respectable. In this article, we decided to focus on Qiagen's ROE. Return on E...

18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker' — Oct 12th, 2024

18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker' Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. As the third-quarter earnings season approaches, Goldman Sachs has issued a note id...

18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker' — Oct 12th, 2024

18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker' Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. As the third-quarter earnings season approaches, Goldman Sachs has issued a note id...

QIAGEN N.V. to release results for Q3 2024 and hold webcast — Oct 10th, 2024

Venlo, The Netherlands, Oct. 10, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the third quarter 2024. Press release date / time: Wednesday, November 6, shortly after 22:05Frankfurt time / 21:05 London time / 16:05...

Qiagen N.V. (NYSE:QGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? — Oct 18th, 2024

With its stock down 6.5% over the past month, it is easy to disregard Qiagen (NYSE:QGEN). However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty respectable. In this article, we decided to focus on Qiagen's ROE. Return on E...

OPK Gets Additional BARDA Funding to Develop Multispecific Antibodies — Oct 11th, 2024

OPKO Health, Inc.’s OPK company, ModeX Therapeutics Inc., was awarded $35 million of additional funding under an existing contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the U.S. Depar...

Qiagen N.V. (NYSE:QGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? — Oct 18th, 2024

With its stock down 6.5% over the past month, it is easy to disregard Qiagen (NYSE:QGEN). However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty respectable. In this article, we decided to focus on Qiagen's ROE. Return on E...

QIAGEN N.V. to release results for Q3 2024 and hold webcast — Oct 10th, 2024

Venlo, The Netherlands, Oct. 10, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the third quarter 2024. Press release date / time: Wednesday, November 6, shortly after 22:05Frankfurt time / 21:05 London time / 16:05...

Qiagen N.V. (NYSE:QGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? — Oct 18th, 2024

With its stock down 6.5% over the past month, it is easy to disregard Qiagen (NYSE:QGEN). However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty respectable. In this article, we decided to focus on Qiagen's ROE. Return on E...

OPK Gets Additional BARDA Funding to Develop Multispecific Antibodies — Oct 11th, 2024

OPKO Health, Inc.’s OPK company, ModeX Therapeutics Inc., was awarded $35 million of additional funding under an existing contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the U.S. Depar...

QIAGEN N.V. to release results for Q3 2024 and hold webcast — Oct 10th, 2024

Venlo, The Netherlands, Oct. 10, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the third quarter 2024. Press release date / time: Wednesday, November 6, shortly after 22:05Frankfurt time / 21:05 London time / 16:05...

18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker' — Oct 12th, 2024

18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker' Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. As the third-quarter earnings season approaches, Goldman Sachs has issued a note id...

Qiagen N.V. (NYSE:QGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? — Oct 18th, 2024

With its stock down 6.5% over the past month, it is easy to disregard Qiagen (NYSE:QGEN). However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty respectable. In this article, we decided to focus on Qiagen's ROE. Return on E...